Fund Holdings — Sands Capital Alternatives, LLC

Total Portfolio Value:
$421.20M
Total Bought:
$145.58M
Total Sold:
$20.91M
Net Transaction:
+$124.67M
Notable People:
Sands Capital Management, Lp, Erin Elizabeth Soule
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Nu Holdings Ltd.CL A(NU)6,861,3996,537,769-323,630$114.86M$93.95M22.30%-$20.91M
Klaviyo, Inc.COM SER A(KVYO)3,649,6783,649,6780$118.51M$71.02M16.86%-$47.48M
SpyGlass Pharma, Inc.(SGP)02,500,012+2,500,012$0$64.78M15.38%+$64.78M
Beta Bionics, Inc.(BBNX)3,570,1133,708,043+137,930$108.78M$37.15M8.82%-$71.63M
Inhibikase Therapeutics, Inc.(IKT)13,018,96513,018,9650$26.69M$21.87M5.19%-$4.82M
Coupang, Inc.CL A(CPNG)870,4241,012,091+141,667$20.53M$19.11M4.54%-$1.43M
Samsara Inc.CL A(IOT)466,190560,287+94,097$16.53M$17.76M4.22%+$1.23M
DoorDash, Inc.CL A(DASH)95,618111,231+15,613$21.66M$16.70M3.97%-$4.95M
BioAge Labs, Inc.(BIOA)786,353786,3530$10.40M$13.75M3.27%+$3.35M
10x Genomics, Inc.CL A(TXG)481,770481,7700$7.86M$10.23M2.43%+$2.37M
Datadog, Inc.CL A(DDOG)85,79385,7930$11.67M$10.13M2.40%-$1.54M
Acumen Pharmaceuticals, Inc.(ABOS)3,417,0753,720,105+303,030$7.21M$8.78M2.08%+$1.57M
Toast, Inc.CL A(TOST)301,647301,6470$10.71M$8.00M1.90%-$2.71M
Tarsus Pharmaceuticals, Inc.(TARS)85,00085,0000$6.96M$5.96M1.42%-$997.0K
ServiceTitan, Inc.CL A(TTAN)89,85689,8560$9.57M$5.70M1.35%-$3.87M
Monday Com LtdSHS
SHS
67,86867,8680$10.01M$4.69M1.11%-$5.32M
Taysha Gene Therapies, Inc.(TSHA)724,873724,8730$3.99M$3.24M0.77%-$746.6K
Snowflake Inc.(SNOW)20,25320,2530$4.44M$3.05M0.73%-$1.39M
Acrivon Therapeutics Inc2,122,6052,122,6050$5.12M$2.95M0.70%-$2.17M
Candel Therapeutics, Inc.(CADL)405,837405,8370$2.29M$1.99M0.47%-$304.4K
Figma, Inc.CL A(FIG)18,28618,2860$683.3K$386.6K0.09%-$296.8K
Page 1 of 1
Sands Capital Alternatives, LLC — 13F Holdings — Q1 2026 | TickerTrail